CRPC w/ Bone Metastases

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421. July 23, 2019

Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel. May 9, 2019

Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States. May 1, 2019

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program. January 11, 2019

Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives. January 4, 2019

Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223. January 3, 2019

Reversibility of castration resistance status after Radium-223 dichloride treatment: Clinical evidence and Review of the literature. December 20, 2018

Evaluating radium-223 response in metastatic castration-resistant prostate cancer with imaging. December 3, 2018

The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer November 23, 2018

Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects October 15, 2018

Targeted Alpha Therapy, an Emerging Class of Cancer Agents - A Review September 21, 2018

Microscopic Imaging Pierces the “Black Box” of Cancer Bone Metastasis August 1, 2018

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial May 17, 2018

Radiation for Treatment of Painful Bone Metastases May 15, 2018

Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases March 20, 2018

Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy March 20, 2018

Optimal usage of radium-223 in metastatic castration-resistant prostate cancer March 14, 2018

The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer March 14, 2018

Radium-223 international early access program: results from the Spanish subset March 14, 2018

Utility of F-18 FDG PET/CT for Detection of Bone Marrow Metastases in Prostate Cancer Patients Treated with Radium-223 March 14, 2018

Page 1 of 10